Windlas Biotech IPO to hit the market on 04 August 2021 and closes on 06 August 2021. The company to raise ₹165 crores via fresh issue and the offer for sale will be 5,142,067 shares as per DRHP, The face value of the Windlas Biotech share is ₹5.
Windlas Biotech IPO date announced, The Windlas IPO to hit the market on 04 August 2021. The company to raise ₹401.54 crores via IPO that comprises fresh issue of ₹165 crores and offer for sale up to 5,142,067 shares of existing share holders. The company incorporated in 2001 based in Dehradun. The registered name of the company is Windlas Biotech Limited (Formerly known as Windlas Biotech Private Limited). They are one of the leading company in pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. They offer pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers. They have over 900 employees with manufacturing facilities in Dehradun. They are doing marketing of their own manufactured authentic nutraceutical, pharmaceutical and ayurvedic products. They are operating with 3 business verticals - 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market (nutraceutical and health supplement products) and 3. Exports. Check out Windlas Biotech IPO details.
Customers of Windlas Biotech:
Customers of Windlas Biotech:
- Pfizer Ltd
- Sanofi India Ltd
- Cadila Healthcare Ltd
- Emcure Pharmaceuticals Ltd
- Eris Lifesciences Ltd
- Intas Pharmaceuticals Ltd
- Systopic Laboratories Private Limited
Fresh Issue of 35,86,956 Shares @ ₹460 = ₹165.00 Crores
Offer for Sale of 51,42,067 Shares ₹460 = ₹236.54 Crores
Equity Shares outstanding after the Issue = 2,17,94,375 Shares
Category-wise Break up:
Anchor: 26,18,707 Shares = ₹120.46 Crores
QIB: 17,45,805 Shares = ₹80.31 Crores
NII: 13,09,353 Shares = ₹60.23 Crores
RII: 30,55,158 Shares = ₹140.54 Crores (Lot size: 30 = 1,01,839 Forms)
Total Issue: 87,29,023 Shares = ₹401.54 Crores
Subscription required for 1X
RII = 1,01,839 Forms
NII = ₹60.23 Crores
Financial Information (Basis of Valuation)
EPS for FY18-19 - ₹37.65 (Page #89 of RHP)
EPS for FY19-20 - ₹08.90 (Page #89 of RHP)
EPS for FY20-21 - ₹08.70 (Page #89 of RHP)
RoNW for FY18-19 - 18.19% (Page #90 of RHP)
RoNW for FY19-20 - 08.04% (Page #90 of RHP)
RoNW for FY20-21 - 08.97% (Page #90 of RHP)
NAV as on March 31, 2021 was Rs.109.36 (Page #90 of RHP)
Windlas Biotech IPO Review
- Apply
Brokerage Firm IPO Reviews
- JM Financial: Neutral
- ICICI Securities: Adding Soon
- Motilal Oswal: Adding Soon
- Capital Market: Adding Soon
- Ventura Securities Limited: Adding Soon
- KR Choksey: Adding Soon
- GEPL Capital Ltd: Adding Soon
Windlas Biotech IPO Date & Price Band
| IPO Open: | 04 August 2021 |
| IPO Close: | 06 August 2021 |
| IPO Size: | Approx ₹401.54 Crores |
| Fresh Issue: | Approx ₹165 Crores |
| Offer for Sale: | Approx ₹236.54 Crores - 5,142,067 Equity Shares |
| Face Value: | ₹5 Per Equity Share |
| Price Band: | ₹448 to ₹460 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Discount: | N/A |
Windlas Biotech IPO Market Lot
The Windlas Biotech IPO minimum market lot is 30 shares with ₹13,800 application amount. The retail investors can apply up-to 14 lots, 420 shares with ₹193,200 application amount.
| Minimum Lot Size: | Minimum 30 Shares |
| Minimum Amount: | ₹13,800 |
| Maximum Lot Size: | Maximum 420 Shares |
| Maximum Amount: | ₹193,200 |
Windlas Biotech IPO Date, Time Table, Allotment & Listing
The Windlas Biotech IPO date is 04 August 2021 and the IPO close date is 06 August 2021. The allotment date is 11 August 2021 and the IPO may list on 17 August 2021.
| Price Band Announcement: | 30 July 2021 |
| Anchor Investors Allotment: | 03 August 2021 |
| IPO Open Date: | 04 August 2021 |
| IPO Close Date: | 06 August 2021 |
| Basis of Allotment: | 11 August 2021 |
| Refunds: | 12 August 2021 |
| Credit to Demat Account: | 13 August 2021 |
| IPO Listing Date: | 17 August 2021 |
Windlas Biotech IPO Form
How to apply the Windlas Biotech IPO? You can apply Windlas Biotech IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Windlas Biotech IPO in the Invest section. The other option you can apply Windlas Biotech IPO via IPO forms download via NSE and BSE. Check out the Windlas Biotech forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.Windlas Biotech Company Financial Report
| ₹ in Crores | |||||
| Assets |
Revenue | PAT |
|||
| 2018 | ₹290 | ₹357 | ₹11.20 | ||
| 2019 | ₹298 | ₹312 | ₹63.82 | ||
| 2020 | ₹338 | ₹331 | ₹16.21 | ||
| 2021 |
₹296 | ₹431 | ₹15.57 | ||
Company Promoters
- Ashok Kumar Windlass
- Hitesh Windlass
- Manoj Kumar Windlass
- AKW WBL Family Pvt Trust
About Windlas Biotech
Founded in the year 2001, Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.
We employ 954 employees at our four state-of-the-art manufacturing facilities in Dehradun, Uttarakhand India. We also have a salesforce and distribution network spread across 14 states. We market our own manufactured authentic nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities at affordable prices. “The registered name of the company is Windlas Biotech Limited (Formerly known as Windlas Biotech Private Limited).”
Innovation is at the core of our spirit at Windlas. We aim to deliver customized, innovative and complex generic products to our customers. Our R&D team work closely with customers or prospective customers, and provide innovative and cost efficient solutions tailored to meet specific customer requirements. When we work on a customer specific project then the customers also oversees the planning and execution of our projects. Our R&D team oversees the transfer of technology from lab scale to plant scale and prepares back-up strategies. Thereafter, we scale-up our operations from the R&D stage to large-scale manufacturing. We emphasize on maintaining consistency in the quality of our products as well as planning and executing projects in a timely manner.
We are constantly focused on improving efficiency of our operations and increasing the value of our research and manufacturing services to our clients. We are proud of our undeterred focus on quality and compliance assurance systems that provide authentic, efficacious and safe products to all patients consuming our products. Our dedication to quality can be seen from the fact that almost 40% of our staff workforce is in Quality Control / Quality Assurance functions.
We employ 954 employees at our four state-of-the-art manufacturing facilities in Dehradun, Uttarakhand India. We also have a salesforce and distribution network spread across 14 states. We market our own manufactured authentic nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities at affordable prices. “The registered name of the company is Windlas Biotech Limited (Formerly known as Windlas Biotech Private Limited).”
Innovation is at the core of our spirit at Windlas. We aim to deliver customized, innovative and complex generic products to our customers. Our R&D team work closely with customers or prospective customers, and provide innovative and cost efficient solutions tailored to meet specific customer requirements. When we work on a customer specific project then the customers also oversees the planning and execution of our projects. Our R&D team oversees the transfer of technology from lab scale to plant scale and prepares back-up strategies. Thereafter, we scale-up our operations from the R&D stage to large-scale manufacturing. We emphasize on maintaining consistency in the quality of our products as well as planning and executing projects in a timely manner.
We are constantly focused on improving efficiency of our operations and increasing the value of our research and manufacturing services to our clients. We are proud of our undeterred focus on quality and compliance assurance systems that provide authentic, efficacious and safe products to all patients consuming our products. Our dedication to quality can be seen from the fact that almost 40% of our staff workforce is in Quality Control / Quality Assurance functions.
Quick Links
DRHP Draft Prospectus
RHP Draft Prospectus
Windlas IPO Allotment Status
Windlas Biotech IPO Registrar
Link Intime India Private LtdC 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: windlas.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
Note: Check Windlas Biotech IPO allotment status on Linkintime website allotment URL. Click Here
40/1, Mohabewala Industrial Area,
Dehradun, 248110
Phone: +91 135 6608000
Email: grievance@windlasbiotech.com
Website: http://www.windlasbiotech.com/
Note: The Windlas Biotech IPO final details is added as it is officially announced. The IPO grey market premium (Windlas Biotech IPO Premium) is started and updated to the respective page. You can check our IPO grey market page for daily updates.)
Windlas Biotech IPO Lead Managers
- DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
- IIFL Holdings Limited
- SBI Capital Markets Limited
Company Address
Windlas Biotech Limited40/1, Mohabewala Industrial Area,
Dehradun, 248110
Phone: +91 135 6608000
Email: grievance@windlasbiotech.com
Website: http://www.windlasbiotech.com/
Windlas Biotech IPO FAQs
What is Windlas Biotech IPO?
Windlas Biotech IPO is a main-board IPO. They are going to raise ₹401.54 Crores via IPO. The issue is priced at ₹448 to ₹460 per equity share. The IPO to be listed on BSE & NSE.
When Windlas Biotech IPO will open?
The IPO is to open on 04 August 2021 for QIB, NII, and Retail Investors.
What is Windlas Biotech IPO Investors Portion?
The investors' portion for QIB 50%, NII 15%, and Retail 35%.
How to Apply the Windlas Biotech IPO?
You can apply Windlas Biotech IPO via ASBA online via your bank account. You can also apply ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the Windlas Biotech IPO through Zerodha?
Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name "Windlas Biotech". Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.
How to Apply the Windlas Biotech IPO through Upstox?
Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name "Windlas Biotech". Click on Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve - mandate. Open Demat Account with Upstox.
What is Windlas Biotech IPO Size?
Windlas Biotech IPO size is ₹401.54 crores. The IPO comprises ₹165 crore of fresh issue and 5,142,067 shares of offer for sale.
What is Windlas Biotech IPO Price Band?
Windlas Biotech IPO Price Band is ₹448 to ₹460 per equity share.
What is Windlas Biotech IPO Minimum and Maximum Lot Size?
The minimum bid is 30 Shares with ₹13,800 amount while maximum bid is 420 shares with ₹193,200.
What is Windlas Biotech IPO Allotment Date?
Windlas Biotech IPO allotment date is 11 August 2021.
What is Windlas Biotech IPO Listing Date?
Windlas Biotech IPO listing date is 17 August 2021. The IPO to list on BSE and NSE.
